Reply to the use of tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy
- PMID: 40347489
- PMCID: PMC12096157
- DOI: 10.1093/europace/euaf101
Reply to the use of tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy
Conflict of interest statement
Conflict of interest: A.L. and S.H. are supported by the Wellcome/EPSRC Centre for Medical Engineering (WT203148/Z/16/Z). NW has received funding from the British Heart Foundation (BHF) (FS/CRTF/22/24362) and travel funding from EBR Systems. C.A.R. receives research funding and/or consultation fees from Abbott, Medtronic, Boston Scientific, Spectranetics, EBR Systems and MicroPort.
Comment on
-
Tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy.Europace. 2025 Mar 28;27(4):euaf043. doi: 10.1093/europace/euaf043. Europace. 2025. PMID: 40205768 Free PMC article.
References
-
- Bleeker GB, Kaandorp TAM, Lamb HJ, Boersma E, Steendijk P, de Roos A et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation 2006;113:969–76. - PubMed
-
- Behar JM, Daniel T, Sabrina R, Maria P, Alexander B, Bernhard F et al. Real-time X-MRI-guided left ventricular lead implantation for targeted delivery of cardiac resynchronization therapy. JACC Clin Electrophysiol 2017;3:803–14. - PubMed
-
- Leclercq C, Burri H, Curnis A, Delnoy PP, Rinaldi CA, Sperzel J et al. Cardiac resynchronization therapy non-responder to responder conversion rate in the more response to cardiac resynchronization therapy with MultiPoint Pacing (MORE-CRT MPP) study: results from Phase I. Eur Heart J 2019;40:2979–87. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
